Stocks Close Mixed

A worse-than-expected read on wholesale inflation weighed on sentiment. Drugmakers got a boost from an FDA ruling on Pfizer's Celebrex

Stocks closed mixed Friday, after the release of a report showing that January core producer prices rose at their highest level in six years. Drugmakers were boosted by a Food and Drug Administration panel ruling that Pfizer's (PFE ) Celebrex painkiller should stay on the market, while rate-sensitive stocks such as banks, brokers and mortgage related firms suffered losses, according to Standard & Poor's MarketScope.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.